Antioxidant property of eupatilin attenuates atherosclerosis and improves adipokine profiles in LDL receptor-deficient mice

被引：0
|
作者：
An, Sojin [1 ]
Han, Jong-Min [1 ]
Park, Ji-Seon [1 ]
Baek, Seung-Hwa [1 ]
Jin, Yue-Yan [1 ]
Cho, Moon-Hee [1 ]
Jeong, Tae-Sook [1 ]
机构：
[1] Korea Rsch Inst Biosci & Biotechnol, Taejon, South Korea
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2008年 / 28卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P485
引用
收藏
页码：E121 / E121
页数：1
相关论文
共 50 条
  • [31] Pioglitozone inhibits the progression, but does not reverse development of atherosclerosis, in LDL receptor-deficient mice
    Nakaya, H
    Nicholson, AC
    Han, J
    Summers, B
    Gotto, AM
    Hajjar, DP
    FASEB JOURNAL, 2006, 20 (05): : A1075 - A1075
  • [32] Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1
    Huszar, D
    Varban, ML
    Rinninger, F
    Feeley, R
    Arai, T
    Fairchild-Huntress, V
    Donovan, MJ
    Tall, AR
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) : 1068 - 1073
  • [33] Vaccination against interleukin 12 attenuates atherosclerosis in LDL receptor deficient mice
    Hauer, A
    Uyttenhove, C
    de Vos, P
    Stroobant, V
    Renauld, J
    van Berkel, T
    van Snick, J
    Kuiper, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 41 - 42
  • [34] Leukocyte Cathepsin C Deficiency Attenuates Atherosclerosis in LDL Receptor Deficient Mice
    Herias, Mayra V.
    Bai, Lili
    Medina, Indira
    Wijnands, Erwin
    Delsing, Dianne
    Pham, Christine
    Biessen, Erik A.
    Heeneman, Sylvia
    CIRCULATION, 2009, 120 (18) : S1166 - S1166
  • [35] CYSTEAMINE (A LYSOSOMOTROPIC ANTIOXIDANT) CAUSES REGRESSION OF ATHEROSCLEROSIS AND IMPROVES LIVER AND MUSCLE FUNCTION IN LDL RECEPTOR DEFICIENT MICE
    Ahmad, F.
    Mitchell, R.
    Houben, T.
    Palo, A.
    Yadati, T.
    Parnell, A.
    Patel, K.
    Shiri-Sverdlov, R.
    Leake, D.
    ATHEROSCLEROSIS, 2021, 331 : E102 - E102
  • [36] Inhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice
    Kanters, E
    Pasparakis, M
    Gijbels, MJJ
    Vergouwe, MN
    Partouns-Hendriks, I
    Fijneman, RJA
    Clausen, BE
    Forster, I
    Kockx, MM
    Rajewsky, K
    Kraal, G
    Hofker, MH
    de Winther, MPJ
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (08): : 1176 - 1185
  • [37] Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice
    Marsh, MM
    Walker, VR
    Curtiss, LK
    Banka, CL
    JOURNAL OF LIPID RESEARCH, 1999, 40 (05) : 893 - 900
  • [38] Site-Specific Effects of PECAM-1 on Atherosclerosis in LDL Receptor-Deficient Mice
    Goel, Reema
    Schrank, Benjamin R.
    Arora, Shikha
    Boylan, Brian
    Fleming, Barbara
    Miura, Hiroto
    Newman, Peter J.
    Molthen, Robert C.
    Newman, Debra K.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (11) : 1996 - 2002
  • [39] 12/15-lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice
    George, J
    Afek, A
    Shaish, A
    Levkovitz, H
    Bloom, N
    Cyrus, T
    Zhao, L
    Funk, CD
    Sigal, E
    Harats, D
    CIRCULATION, 2001, 104 (14) : 1646 - 1650
  • [40] Effects of diabetes and CETP expression on diet-induced atherosclerosis in LDL receptor-deficient mice
    Berti, JA
    Salerno, AG
    Bighetti, EJB
    Casquero, AC
    Boschero, AC
    Oliveira, HCE
    APMIS, 2005, 113 (01) : 37 - 44
12345